NewsOther VideosPoliticsUS NewsVideos

Elon Musk’s 20-Pill Box, Ketamine Bladder Scare, and the White House Access Nobody Drug-Tested

Bombshell new report on Musk’s ‘intense’ use of ketamine, other drugs

The New York Times did not accuse Elon Musk of taking a prescribed ketamine lozenge once in a clinic. The May 30, 2025 investigation said he told people he was using the anesthetic so often that it was damaging his bladder, that he also took MDMA and psilocybin, and that he traveled with a daily box holding about 20 pills, including tablets with Adderall markings. The same reporting placed that habit on the 2024 campaign trail and inside the orbit of Donald Trump’s White House, where Musk ran the Department of Government Efficiency without a Senate-confirmed job and without a drug test that anyone in Congress could point to.

Musk called the paper a liar. He later posted a urine screen dated June 11, 2025, that appeared to show negative results for a panel of substances, including ketamine. The Times said nothing in that photo contradicted what sources described about 2024. Those two sentences are the fight. They are also why the original « 20 pills a day » headline still matters more than a year later: the richest man in the room had the keys to federal agencies while the people around him were arguing about whether he could pee normally.

Illustration of Elon Musk with pills and mushrooms used in The AEGIS Alliance coverage of alleged White House drug use.
Reports said Musk’s frequent ketamine use may have led to bladder issues. (Ideogram AI)

What the Times actually reported, and what Musk posted back

The New York Times article described consumption that « went well beyond occasional use. » Sources said Musk used ketamine far more intensely than the biweekly therapeutic dose he had previously advertised. He told people the drug was affecting his bladder, a known injury from chronic ketamine exposure. He took ecstasy and psychedelic mushrooms. A photograph of a daily organizer, according to people who had seen the box, showed about 20 pills.

Musk had already told Don Lemon that ketamine helped with depression and that too much of it would keep him from working. After the Times story, he posted that he was « NOT taking drugs, » that he had tried prescription ketamine years earlier, and that the paper was « lying their ass off. » In June he posted the lab image with the caption « lol. » The Times public-relations account answered that he was lashing out because he disliked the reporting and that the 2024 record still stood.

That exchange is not a medical chart. It is a power chart. A sitting president’s closest unelected adviser was being asked, in public, whether he was dissociating on federal time.

Ketamine is not a vibe. It is an anesthetic with a bladder bill

Ketamine began as a surgical anesthetic. Clinics later marketed low-dose versions for treatment-resistant depression. Recreational and high-frequency use is a different file. Chronic exposure is tied to ketamine cystitis: pain, bleeding, urgency, and a bladder lining that starts to fail. Studies in medical journals have described epithelial damage and long-term urinary injury. Cognitive effects — memory gaps, attention problems, lingering dissociation — show up in the same literature.

The Times report did not invent that risk. Musk himself, according to the paper, named the bladder problem to people around him. That is the detail that separates a wellness anecdote from a workplace question. If the man redesigning agencies cannot trust his own urinary tract, Congress is entitled to ask who was watching the decisions.

Representative Mikie Sherrill of New Jersey had already floated legislation to put Musk and DOGE staff on a drug-testing schedule. The bill was a message more than a statute. It said the people with the most sensitive federal data should not be the people least willing to pee in a cup.

The White House chapter did not end with a clean goodbye

Musk’s unofficial run at the Department of Government Efficiency produced mass firings, public fights with cabinet officials, and a sendoff that included a black eye and a Times story landing on the same news cycle. He left the building in May 2025. Within days he and Trump were insulting each other in public. Musk called the president’s signature spending bill a betrayal of the waste-cutting mission. He claimed Trump would have lost in 2024 without him. He floated the idea that the president’s name sits in unreleased Epstein files. Trump mused about cutting the federal contracts that keep SpaceX and related companies paid and even talked about looking at deportation.

Musk later said some posts « went too far. » The truce did not hold. By July 2025 the insults were back. Tesla’s market value took the kind of hit that only happens when a chief executive turns a political alliance into a knife fight. The drug story did not cause that feud. It sat underneath it. Advisers who thought Musk was impaired in 2024 now had a public record to point at while the same man was picking a war with the president who had given him the building.

The AEGIS Alliance has already covered how official secrecy works when powerful men want a file buried, including the Justice Department’s admission that almost none of the Epstein records have been released. Musk’s decision to weaponize those files in a social-media argument with Trump is not a side note. It is what happens when a billionaire treats classified gossip and ketamine rumors as interchangeable ammunition.

Why « I can still work » is not a security clearance

Musk’s favorite defense has always been output. If the rockets launch and the cars ship, the pills cannot have been a problem. That is a founder’s metric. It is not a government’s metric. The people who sit in the Oval Office with him do not get to invent a private standard for impairment. Airline pilots do not. Nuclear officers do not. The man who was telling agencies which employees to fire decided he was the exception.

TIME’s account of the Oval Office questions and Axios coverage of the same week captured the political cost. Democrats asked for tests. Republicans treated the story as media malice. Nobody produced a contemporaneous workplace test from the months when Musk had the most access. The June 2025 urine screen, even if authentic, measures one day after the government chapter. It does not audit the campaign.

Readers who follow this desk’s politics and US news coverage already know the pattern. When the subject is poor, a dirty urine screen ends a job. When the subject is the world’s richest man, the screen becomes content.

What the file still does not answer

The Times stood by the 2024 reporting. Musk stood by the denial and the later lab image. There has been no public, independent audit of what he ingested while he sat in the White House. There has been no official finding that he was impaired on a specific date. There has also been no official finding that he was clean on the days that mattered.

That vacuum is the story The AEGIS Alliance is leaving on the page. A daily 20-pill box, a bladder complaint, a presidential partnership, a public breakup, and a negative test posted like a meme do not cancel one another. They stack. The country let an unelected executive wander through federal systems while the only drug policy in the room was his own word.

If ketamine was medicine, the prescription should have been boring and documented. If it was a habit that worried the people next to him, the clearance process failed in public. Either way, the pills were never a private matter once he walked into the building.

Kyle James Lee
Majority Owner of The AEGIS Alliance. I studied in college for Media Arts, Game Development. Talents include Writer/Article Writer, Graphic Design, Photoshop, Web Design and Development, Video Production, Social Media, and eCommerce.

Articles similaires

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Bouton retour en haut de la page
Signup for our news and memes newsletters! 

Newsletter Form

Lists
close-link